How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

18,293 results for

"grant funding" or "obtaining grants" or "getting grants" or "grant awards" or (grants and "how to")

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

17821. Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment

for investigator information Principal Investigator: Juliana B Diniz, MD University of Sao Paulo Medical School More Information Go to Additional Information: Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: Juliana Belo Diniz, MD, PhD, University of Sao Paulo ClinicalTrials.gov Identifier: Other Study ID Numbers: 05/55628-8 2005/55628-08 ( Other Grant/Funding Number: FAPESP ) First Posted: April 27, 2007

2007 Clinical Trials

17822. Effect of Daily Calorie or Alternate-day Calorie Reductions on Risk for Cardiovascular Disease and Cancer

Sponsors and Collaborators University of California, San Francisco National Institutes of Health (NIH) Investigators Layout table for investigator information Principal Investigator: Marc Hellerstein, MD, PhD University of California, Berkeley; University of California, San Francisco More Information Go to Layout table for additonal information Responsible Party: University of California, San Francisco ClinicalTrials.gov Identifier: Other Study ID Numbers: H3049-30095-01 NIH-PPG ( Other Grant/Funding

2007 Clinical Trials

17823. Role of Placenta Growth Factor in Sickle Acute Chest Syndrome

for additonal information Responsible Party: Children's Hospital Medical Center, Cincinnati ClinicalTrials.gov Identifier: Other Study ID Numbers: CCHMC 06-09-57 R01 ( Other Grant/Funding Number: HL079916 ) First Posted: March 16, 2007 Last Update Posted: December 21, 2017 Last Verified: December 2017 Keywords provided by Children's Hospital Medical Center, Cincinnati: Anemia, sickle cell Additional relevant MeSH terms: Layout table for MeSH terms Anemia, Sickle Cell Acute Chest Syndrome Anemia, Hemolytic

2007 Clinical Trials

17824. Integrated Treatment to Persons With Mental Disorders and Co-occurring Substance Use Disorders

Identifier: Other Study ID Numbers: 78i068 NFR175394/V50 ( Other Grant/Funding Number: The Norwegian Research Council/NFR175394/V50 ) First Posted: March 15, 2007 Last Update Posted: March 26, 2012 Last Verified: March 2012 Keywords provided by Rolf W. Grawe, University of Oslo: mental health substance use treatment Additional relevant MeSH terms: Layout table for MeSH terms Disease Anxiety Disorders Mental Disorders Psychotic Disorders Mood Disorders Substance-Related Disorders Pathologic Processes

2007 Clinical Trials

17825. Study of Dust Mite Inhalation in Humans

Carolina, Chapel Hill ClinicalTrials.gov Identifier: Other Study ID Numbers: 06-0528 NHLBI-RO1 HL080337 ( Other Grant/Funding Number: National Heart, Lung, and Blood Institute (NHLBI) ) First Posted: March 19, 2007 Last Update Posted: December 10, 2013 Last Verified: December 2013 Keywords provided by David B. Peden, MD, University of North Carolina, Chapel Hill: asthma allergy (...) , University of North Carolina, Chapel Hill Study Details Study Description Go to Brief Summary: The purpose of this research study is to learn more about the effect of inhaled dust mite allergen extract on airway responses in allergic individuals with mild asthma. Information learned from this study will be used to identify a safe dose range of D Farinae extract for use in inhalation challenge studies. This study will also help determine how inhalation of the allergen affects mucociliary clearance (MCC

2007 Clinical Trials

17826. Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

or disease progression. Patients are followed at 1, 3, 6,12,15,18, 21, 24 months following the start of the last treatment cycle. Cohorts of 3-6 patients each will receive escalating doses of recombinant CAT-8015 until the maximum tolerated dose (MTD) is determined. The MTD is defined as the dose proceeding that at which 2 of 3 or 2 of 6 patients experience dose-limiting toxicity. Once the MTD is determined, between16 to 25 new patients will be added to the MTD cohort depending on how well the CAT-8015 (...) University School of Medicine Not yet recruiting Stanford, California, United States, 94305 Contact: Sylvia Quesada, RN 650-725-4041 Principal Investigator: Steven E Coutre, MD United States, Illinois Cancer Center of Northwestern University Not yet recruiting Chicago, Illinois, United States, 60611 Contact: Simbi Acharya 312-695-1383 Principal Investigator: Martin Tallman, MD United States, Maryland Warren Grant Megnuson Clinical Center – NCI Clinical Trials Referral Office Recruiting Bethesda, Maryland

2007 Clinical Trials

17827. Medication and Counseling for Controlled Drinking (Project SMART)

Kuerbis, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Study Details Study Description Go to Brief Summary: The purpose of this study is to study the effectiveness of medication and specialized psychotherapy in helping gay and bisexual men who do not want to quit drinking learn how to reduce their drinking to healthier levels. More information on the study is available at www.projectsmartnyc.org. Condition or disease Intervention/treatment Phase Alcohol-related Disorders Alcohol Drinking (...) and Alcoholism (NIAAA) Investigators Layout table for investigator information Principal Investigator: Jon Morgenstern, PhD Columbia University More Information Go to Layout table for additonal information Responsible Party: Alexis Kuerbis, Co-Investigator, National Institute on Alcohol Abuse and Alcoholism (NIAAA) ClinicalTrials.gov Identifier: Other Study ID Numbers: NIAAAMOR_015553-01A1S1 NIH Grant AA015553-01A1S1 First Posted: March 7, 2007 Last Update Posted: May 1, 2013 Last Verified: April 2013

2007 Clinical Trials

17828. The Influence of Vibration on Bone Mineral Density in Women Who Have Weak Bones After Menopause

Party: PI - Dr. Angela M. Cheung, University Health Network/University of Toronto ClinicalTrials.gov Identifier: Other Study ID Numbers: 06-0332-AE PSI 06-28 ( Other Grant/Funding Number: The Physicians' Services Incorporated Foundation ) First Posted: January 11, 2007 Last Update Posted: April 8, 2010 Last Verified: October 2008 Keywords provided by University Health Network, Toronto: vibration mechanical loading bone mineral density women's health osteoporosis Additional relevant MeSH terms (...) studies have found that whole-body vibration slowed down bone loss in postmenopausal women. One of the reasons why different studies found different results may be because they used various speeds of vibration. This study looks at how different speeds of whole-body vibration influence bone mineral density differently in postmenopausal women who have osteopenia. Two hundred postmenopausal women will take part in this 12-month study. Women will be randomly assigned into three groups (67 women per group

2007 Clinical Trials

17829. A Study of Taurine in Patients With First-episode Psychosis Receiving Antipsychotic Treatment

by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: Melbourne Health ClinicalTrials.gov Identifier: Other Study ID Numbers: MHREC 2006/040 SMRI Grant ID Number 06T-811 ( Other Grant/Funding Number: Stanley Medical Resarch Institute ) First Posted: January 11, 2007 Last Update Posted: November 20, 2015 Last Verified: November 2015 Keywords provided by Melbourne Health: First Episode Psychosis Additional relevant MeSH terms: Layout table for MeSH terms Psychotic

2007 Clinical Trials

17830. Low Glycemic Index Diets vs. High Cereal Fibre Diets in Type 2 Diabetes

. Michael's Hospital More Information Go to Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Layout table for additonal information Responsible Party: David Jenkins, Professor, University of Toronto ClinicalTrials.gov Identifier: Other Study ID Numbers: REB 04-021 CIHR RCT#: 67894 ( Other Grant/Funding Number: CIHR ) First Posted: February 22, 2007 Last Update Posted: December 16, 2015 Last Verified: December 2015 Keywords provided by David Jenkins

2007 Clinical Trials

17831. Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III

ClinicalTrials.gov Identifier: Other Study ID Numbers: N01NS42361_NPTUNE01 HHSN265200423611C ( Other Grant/Funding Number: NIH Contract ) First Posted: February 23, 2007 Results First Posted: February 12, 2010 Last Update Posted: September 8, 2010 Last Verified: August 2009 Keywords provided by Westat: spinal muscular atrophy type II/III SMA type II/III spinal muscular atrophy SMA sodium phenylbutyrate motor neuron disease neuromuscular survival motor neuron SMN dose escalation Additional relevant MeSH terms (...) mRNA and protein levels through the 12 week study drug administration period. Potential participants will be screened by having their complete medical and treatment histories recorded, as well as undergoing a physical examination, laboratory tests, and an electrocardiogram (EKG). Parents of eligible participants will receive a supply of sodium phenylbutyrate and instructions on how to administer the drug. Participants will return to the clinic on days 8, 22, 29, and at weeks 8 and 12 of the study

2007 Clinical Trials

17832. Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Type I

information Responsible Party: René Gonin, PhD (Math. Stats.), Senior Biostatistician and NPTUNE Principal Investigator, Westat ClinicalTrials.gov Identifier: Other Study ID Numbers: N01NS42361_NPTUNE02 HHSN265200423611C ( Other Grant/Funding Number: NIH Contract ) First Posted: February 23, 2007 Results First Posted: July 20, 2010 Last Update Posted: November 9, 2010 Last Verified: May 2009 Keywords provided by Westat: spinal muscular atrophy type I SMA type I spinal muscular atrophy SMA sodium (...) will be screened by having their complete medical and treatment histories recorded, as well as undergoing a physical examination, laboratory tests, and an electrocardiogram (EKG). Parents of eligible participants will receive a supply of sodium phenylbutyrate and instructions on how to administer the drug. Participants will return to the clinic on days 8, 22, 29, and at weeks 8 and 12 of the study to update their medical and treatment histories, have a physical exam, and have blood and urine collected

2007 Clinical Trials

17833. Hydroxychloroquine in Giant Cell Arteritis

Information: Publications: Layout table for additonal information Responsible Party: University Hospital, Toulouse ClinicalTrials.gov Identifier: Other Study ID Numbers: 0102808 PHRC 2001 ( Other Grant/Funding Number: Ministry of Health ) First Posted: February 2, 2007 Last Update Posted: October 6, 2015 Last Verified: October 2015 Keywords provided by University Hospital, Toulouse: giant cell arteritis, hydroxychloroquine, corticosteroid sparing, corticodependence Additional relevant MeSH terms: Layout

2007 Clinical Trials

17834. Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin Deficiency

-OBA 0404-638 ( Registry Identifier: Gene Therapy Protocol Number ) NCRR-supported GCRC# 611 ( Other Identifier: University of Florida ) UF IBC RD 2630 ( Other Identifier: University of Florida ) AGTC-AAV1-001 ( Other Identifier: Applied Genetics Technologies C ) WIRB # 20052374 ( Other Identifier: Western Institutional Review B ) BB-IND 12728 ( Other Identifier: FDA ) RR00032, RR00082 ( Other Grant/Funding Number: NCRR ) First Posted: February 2, 2007 Results First Posted: December 15, 2016 Last

2007 Clinical Trials

17835. Maintenance Therapy Using Lenalidomide in Myeloma

Numbers: 0400401 French PHRC ( Other Grant/Funding Number: 0400401 ) First Posted: February 1, 2007 Last Update Posted: January 5, 2018 Last Verified: January 2018 Keywords provided by University Hospital, Toulouse: Myeloma Revlimid Maintenance therapy Autologous Stem Cell Transplantation Additional relevant MeSH terms: Layout table for MeSH terms Multiple Myeloma Neoplasms, Plasma Cell Neoplasms by Histologic Type Neoplasms Hemostatic Disorders Vascular Diseases Cardiovascular Diseases

2007 Clinical Trials

17836. Effects of Acupoint Electro-stimulation on Preventing Nausea and Vomiting Induced by Cisplatin or Oxaliplatin

, 2007 Last Update Posted : February 21, 2018 Sponsor: M.D. Anderson Cancer Center Collaborator: National Cancer Institute (NCI) Information provided by (Responsible Party): M.D. Anderson Cancer Center Study Details Study Description Go to Brief Summary: Objectives: This protocol is part of a larger grant funded by the NCI to create an international research center to study Traditional Chinese Medicine (TCM). All of the patients enrolled in this study will be treated at the Cancer Hospital, Fudan (...) table for additonal information Responsible Party: M.D. Anderson Cancer Center ClinicalTrials.gov Identifier: Other Study ID Numbers: 2006-0735 U19 CA12150301 ( Other Grant/Funding Number: NCI ) NCI-2012-02114 ( Registry Identifier: NCI CTRP ) First Posted: February 1, 2007 Last Update Posted: February 21, 2018 Last Verified: February 2018 Layout table for additional information Studies a U.S. FDA-regulated Drug Product: No Studies a U.S. FDA-regulated Device Product: No Keywords provided by M.D

2007 Clinical Trials

17837. Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer

Numbers: M06OVH-OVHIPEC 2006-003466-34 ( EudraCT Number ) 2006-16 ( Other Grant/Funding Number: Commissie Klinische Studies ) First Posted: January 24, 2007 Last Update Posted: August 24, 2018 Last Verified: August 2017 Keywords provided by The Netherlands Cancer Institute: Ovarian Cancer stage III hyperthermic intraperitoneal chemotherapy debulking surgery HIPEC Additional relevant MeSH terms: Layout table for MeSH terms Ovarian Neoplasms Carcinoma, Ovarian Epithelial Fever Endocrine Gland Neoplasms

2007 Clinical Trials

17838. Job Adaptation in Patients With Rheumatoid Arthritis

to Brief Summary: The specific aim of this study is to compare the rate of negative work role events in individuals with rheumatoid arthritis compared to healthy controls. Condition or disease Rheumatoid Arthritis Detailed Description: Rheumatoid arthritis can cause multiple socio-medical disabilities, with work disability among the most marked. While a major focus has been documenting the rates of job loss and returning patients to the workforce, there is little information about how to foster job (...) English or Spanish; or their physicians do not grant permission to enroll them. Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00412399 Locations Layout table for location information United States, New York Cornell Internal Medicine Associates New

2006 Clinical Trials

17839. Randomised Ischaemic Mitral Evaluation (RIME) Trial

Investigator: Marcus Flather, MBBS, FRCP Royal Brompton Hospital NHS Trust, London Principal Investigator: K. M. John Chan, FRCS CTh Royal Brompton Hospital NHS Trust, London More Information Go to Publications of Results: Other Publications: Layout table for additonal information Responsible Party: Imperial College London ClinicalTrials.gov Identifier: Other Study ID Numbers: 2006HS020B NIHR Portfolio ID 4129 ( Other Grant/Funding Number: National Institute for Health Research ) First Posted: December 20

2006 Clinical Trials

17840. Does Erythropoietin Improve Outcome in Very Preterm Infants?

ClinicalTrials.gov Identifier: Other Study ID Numbers: 3200B0-108176 RoFAR ID 2127989593 ( Other Grant/Funding Number: 3200B0-108176 ) 3200B0-108176 ( Other Grant/Funding Number: SNF 3200B0-108176 ) First Posted: December 20, 2006 Last Update Posted: October 30, 2018 Last Verified: October 2018 Keywords provided by Bucher Hans Ulrich, Swiss Neonatal Network: Premature infant developmental outcome Additional relevant MeSH terms: Layout table for MeSH terms Hemorrhage Cerebral Palsy Intracranial Hemorrhages

2006 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>